⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
LpD3.5 Postbiotic
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-31 — LpD3.5 Intervention Study in Older Adults- LISA-I Trial: 2026 — LISA-I trial protocol registered: 60-day randomized placebo-controlled study of heat-inactivated LpD3.5 in adults ≥60 with MCI, measuring gut permeability, inflammation, microbiome composition, and cognition (protocol only, no efficacy readout). [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
31-aug-2026
novelty 3
per-area 3
strengthens